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ABSTRACT  31 
Background: Congenital cataract displays large phenotypic (syndromic and isolated cataracts) 32 
and genetic heterogeneity. Mutations in several transcription factors involved in eye 33 
development, like PITX3, have been associated with congenital cataracts and anterior segment 34 
mesenchymal disorders. 35 
Materials and methods: Targeted sequencing of 187 genes involved in ocular development was 36 
performed in 96 patients with mainly anophthalmia and microphthalmia. Additionally, Sanger 37 
sequencing analysis of PITX3 was performed on a second cohort of 32 index cases with 38 
congenital cataract and Peters anomaly and/or sclereocornea. 39 
Results: We described five families with four different PITX3 mutations, two of which were 40 
novel. In family 1, the heterozygous recurrent c.640_656dup (p.Gly220Profs*95) mutation 41 
cosegregated with eye anomalies ranging from congenital cataract to Peters anomaly. In family 2, 42 
the novel c.669del (p.(Leu225Trpfs*84)) mutation cosegregated with dominantly inherited eye 43 
anomalies ranging from posterior embryotoxon to congenital cataract in heterozygous carriers 44 
and congenital sclereocornea and cataract in a patient homozygous for this mutation. In family 3, 45 
we identified the recurrent heterozygous c.640_656dup (p.Gly220Profs*95) mutation segregating 46 
with congenital cataract. In family 4, the de novo c.582del (p.(Ile194Metfs*115)) mutation was 47 
identified in a patient with congenital cataract, microphthalmia, developmental delay and autism. 48 
In family 5, the c.38G>A (p.Ser13Asn) mutation segregated dominantly in a family with Peters 49 
anomaly, which is a novel phenotype associated with the c.38G>A variant compared with the 50 
previously reported isolated congenital cataract.  51 
Conclusions: Our study unveils different phenotypes associated with known and novel mutations 52 
in PITX3, which will improve the genetic counselling of patients and their families. 53 
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INTRODUCTION 71 
 72 
Congenital cataract affects 72 per 100,000 newborns in developed countries [1]. Congenital 73 
cataract can be presented as the only clinical feature (isolated) or in association with other ocular 74 
or extraocular abnormalities. It displays large phenotypic and genetic heterogeneity. Mutations in 75 
genes coding for proteins essential for the development and integrity of the lens, such as 76 
connexins and crystallins, can cause isolated cataract [2,3]. In contrast, mutations in different 77 
transcription factors involved in gene regulation during eye development such as PAX6 [4], 78 
FOXE3 [5], PITX2 [6], FOXC1 [7], MAF [8], EYA1 [9] and PITX3 [10] are associated with 79 
congenital cataract and anterior segment mesenchymal disorders (ASMD), such as Peters 80 
anomaly.  81 
PITX3 codes for the paired-like homeodomain transcription factor 3 and is a member of the 82 
RIEG/PITX homeobox gene family [11]. PITX3 appears to have a conserved role in ocular 83 
development throughout vertebrates. In mouse models, a recessive mutation in Pitx3 (aphakia 84 
mouse) results in microphthalmia and absent lenses [12,13]. Similarly, morpholino knockdown of 85 
pitx3 in zebrafish results in abnormalities in the development of the retina and lens [14]. 86 
The PITX3 protein has two different domains, a N-terminal homeodomain and a C-terminal otp, 87 
aristaless, and rax (OAR) domain, which are also characteristic of the other members of 88 
RIEG/PITX homeobox gene family [11]. To date, five frameshift mutations, all located N-89 
terminal of the OAR domain, have been described in 16 index cases displaying eye anomalies 90 
with variable expressivity ranging from mild conditions, such as posterior embryotoxon, to more 91 
severe ones such as Peters anomaly [10,15-20]. In contrast, only one heterozygous missense 92 
mutation located upstream of the homeodomain (p.Ser13Asn), and associated with congenital 93 
cataract and glaucoma, has been identified [10,15,17-20]. Only three patients from two families 94 
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with homozygous PITX3 mutations have been reported so far. They presented with a more severe 95 
ocular phenotype (ASMD, microphthalmia) than the heterozygous family members which was, 96 
besides, occasionally accompanied by neurological features [15,17]. 97 
In this study, we describe phenotypes associated to new and known heterozygous mutations in 98 
PITX3 as well as we present the third family ever described with a homozygous mutation in this 99 
gene.  100 
 101 
MATERIALS AND METHODS 102 
 103 
Patients, targeted and Sanger sequence analyses  104 
The current cohort study was approved by the Cambridgeshire 1 Ethics Committee 105 
04/Q0104/129 and by the French Ethics Committee “Comité de Protection des Personnes (CPP) 106 
Sud-Ouest et Outre-Mer II”. Written informed consent was obtained from all participating 107 
subjects. 108 
The medical history was taken from all participants. All patients were assessed by an 109 
ophthalmologist and a geneticist/paediatrician.  110 
The first patient cohort together with the molecular and analysis methods used for targeted 111 
sequencing were previously described by Chassaing et al. (2016) [21]. Shortly, this cohort 112 
consisted of 96 patients with mainly anophthalmia and microphthalmia (AM), with or without 113 
other ocular or systemic anomalies, for whom previous molecular screening of four of the main 114 
AM genes (SOX2, OTX2, RAX, and VSX2) did not reveal any positive diagnosis. They were 115 
subsequently targeted sequenced for 186 known and candidate genes involved in ocular 116 
development, including PITX3 (Table S1). 117 
 118 
7 
 
Due to the involvement of PITX3 mutations in families with congenital cataract and AM along 119 
with Peters anomaly and/or sclereocornea, a second patient cohort of 32 index cases with 120 
congenital cataract and Peters anomaly and/or sclereocornea (and/or a family history thereof) was 121 
screened for mutations in PITX3 by Sanger sequencing. 122 
 123 
Primers for amplification and sequencing of exons and exon-intron boundaries of PITX3 124 
(ENST00000370002) are shown in Table S2. Amplification by PCR was performed on 25 ng of 125 
genomic DNA with Taq DNA polymerase (Life Technologies, Carlsbad, CA, USA). PCR 126 
fragments were purified with a gel extraction kit (Neo Biotech CliniSciences, Nanterre, France) 127 
in accordance with manufacturer’s protocol. Sequence analysis was performed with the 3500xL 128 
sequencer (Applied Biosystems, Foster city, CA, USA).  129 
 130 
Co-segregation of each mutation was performed by Sanger sequencing in all available family 131 
members. 132 
 133 
Potential mosaicism was assessed in an asymptomatic heterozygous carrier in Family 5 by means 134 
of Digital Droplet PCR (ddPCR) assays with the Droplet Digital PCR QX200 System (Bio-Rad 135 
Laboratories, Hercules, USA) using a commercial TaqMan SNP Genotyping assays (ID: 136 
C_1007168_10; Thermo Fisher, Foster city, CA, USA) to genotype the previously known PITX3 137 
variant (c116C>G; p.(Thr39Arg)). 138 
 139 
  140 
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RESULTS 141 
 142 
Description of PITX3 mutations 143 
 144 
Four mutations in PITX3 were identified in five different families (Figures 1 and 2): two by 145 
screening a panel of 187 genes (families 1 and 4), and the other two by Sanger sequencing PITX3 146 
(families 2, 3 and 5). These mutations were associated with various ocular developmental 147 
disorders within the five families (comprising 12 affected individuals in total). Three of them 148 
(c.582del, p.(Ile194Metfs*115)), c.640_656dup (p.(Gly220Profs*95), and c.669del 149 
(p.(Leu225Trpfs*84)) were frameshift mutations and one was a missense mutation (c.38G>A, 150 
p.Ser13Asn). The c.669del and c.582del variants were novel.  151 
Except for the previously reported c.38G>A variant, which was present in 1/78742 alleles in the 152 
ExAC database and in 1/225438 alleles in the gnomAD database, the other ones have not been 153 
reported before in the NCBI dbSNP138 database, the NHLBI Exome Sequencing Project, the 154 
1000 genomes project, the gnomAD, the GME and the ExAC databases. As depicted in Figure 3, 155 
all frameshift mutations identified in PITX3 were N-terminal of the OAR domain while the 156 
missense mutation (p.Ser13Asn) was N-terminal of the homeodomain.  157 
All mutations presented in this manuscript were submitted to the Leiden Open Variant Database 158 
with the following IDs: 00001632110, 0000163211, 00001632112, 0000163213 and 159 
0000163214. 160 
 161 
 162 
 163 
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Phenotypes of subjects harboring PITX3 mutations 164 
 165 
Mutations in PITX3 were identified in five families (12 affected cases).  166 
 167 
Family 1, heterozygous c.640_656dup (p.Gly220Profs*95) mutation: A large French 168 
family (Figure 1A) with autosomal dominant cataract with a large intra-familial variability 169 
ranging from congenital cataract to Peters anomaly, was ascertained. The index case (II:5) 170 
presented with Peters anomaly in one eye and cataract in the other eye. His mother (I:3) was not 171 
affected, however, his deceased father (I:4) had presented with posterior embryotoxon and 172 
congenital cataract. The index case had an older brother (II:4) who presented with congenital 173 
bilateral cataract that were operated at the ages of 30 (right eye) and 33 (left eye). The II:4 case 174 
had a seven months old child (III:3) with Peters anomaly and posterior embryotoxon. The 175 
younger sister (II:7) presented with congenital cataract operated at the age of 14 years old. The 176 
younger brother (II:6) was unaffected. A paternal cousin was identified by history with unilateral 177 
congenital cataract. General physical examination and history did not reveal any additional ocular 178 
or extra-ocular abnormalities. 179 
 180 
 Family 2, homozygous c.669del (p.(Leu225Trpfs*84)) mutation: A consanguineous family 181 
from Iraq (Figure 1B) was ascertained due to the proband, II:1, having bilateral congenital 182 
sclerocornea and ASMD, identified on neonatal screening. No ocular abnormalities were detected 183 
in her dizygotic twin, II.2. They were born prematurely (27 weeks of gestation, 960 g) by 184 
caesarean section. Transthoracic, transfontanelle and abdominal ultrasound examinations did not 185 
reveal anomalies. No infection was reported during pregnancy. At 14 months of age, the proband 186 
was unable to sit unaided. At that time, her length was 72.5 cm (-0.75 SD), weight was 8.85 kg (-187 
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0.5 SD) and OFC was 44.5 cm (-0.1 SD). She had plagiocephaly, metopic ridge and a thin upper 188 
lip, as well as broad thumbs and clinodactyly of the 5th finger. At two years of age, the index case 189 
developed bilateral buphthalmos. At that time, wearing glasses, she could follow the movement 190 
of bright objects. Her mother, I.1, presented with nasal and temporal posterior embryotoxon in 191 
the right eye and temporal posterior embryotoxon in the left eye. Her father, I:2, presented with 192 
congenital bilateral cataract associated with nasal posterior embryotoxon in the left eye. Her twin 193 
brother had nasal posterior embryotoxon in the left eye. Her father reported that his two siblings 194 
presented early onset cataract-like symptoms. The index’s parents were first cousins. 195 
  196 
 197 
Family 3, c.640_656dup (p.Gly220Profs*95) heterozygous mutation: A small family from 198 
France (Figure 1C) was ascertained as the index case (II:2) presented with Peters anomaly at 199 
three months of age. The karyotype and array analyses of this patient were normal. General 200 
physical examination showed short stature (-3SD), weight (-1.2 SD) and OFC (-0.7 SD), facial 201 
features (prominent forehead, short nose, short columella, long philtrum, thin upper lip, full 202 
cheeks), genu valgum, lax elbow joints and short hands with tapering fingers. He had a 203 
psychomotor delay; he sat at 12 months and walked at 21 months of age. Because of the 204 
diagnosis of Peters plus syndrome, molecular sequencing for B3GLCT was performed and it did 205 
not reveal any mutations [22]. His mother, I.2, had a family history of juvenile bilateral cataract 206 
and had cataract surgery at the age of 18. His father, I.1, was unaffected. His mother reported that 207 
more family members on her side were affected with congenital or juvenile cataract; however, we 208 
did not have access to their clinical data. 209 
 210 
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Family 4, heterozygous c.582del (p.(Ile194Metfs*115)) mutation (de novo): A family trio 211 
from North Ireland was ascertained (Figure 1D). The index case (II:1) was a 12 year-old boy born 212 
10 days post term following a normal pregnancy (except for some early bleeding in pregnancy) 213 
with a birth weight of 3900 g. He was diagnosed with bilateral congenital cataract and 214 
microphthalmia on day 1 because of no red reflex. He had bilateral cataract surgery at three 215 
weeks of age and was fitted with contact lenses. He subsequently had a left broad iridectomy, 216 
with capsulotomy and vitrectomy at the age of four months, a left Ahmed valve insertion at seven 217 
months of age and right inferior oblique anteriorisation (squint surgery) at two years of age. At 218 
two years seven months of age, he had severe visual impairment with navigational vision. His 219 
early motor milestones were delayed: he sat independently at 11 months of age. However, he 220 
started walking at 12 months, and then steadily at 15 months. He had early behavioral issues with 221 
constant crying and was delayed in acquiring social skills. His first word was around one year. 222 
He needed speech therapy to improve clarity of speech. He was later diagnosed with autism 223 
which at the age of 12 years was severe. His growth was initially around the 90th % for height and 224 
weight until recently when he became average height. There is a family history of autistic 225 
spectrum disorder in three male cousins and epilepsy in a female cousin, all on the maternal side. 226 
At age 12 years, he had a head circumference of 55.7 cm (50th-75th %), height 147.3cm (50th%) 227 
and weight 36.9kg (9-25th%). He had a double row of teeth, but no other dysmorphic features. He 228 
had bilateral microphthalmia, cloudy corneas with a corneal diameter of 9 mm bilaterally, was 229 
aphakic with a broad iridectomy on the left eye and a small pupil on the right. Parental eye 230 
examinations showed the mother had very slight enlargement of the optic cups, and the father had 231 
tilted myopic optic discs only. Array and chromosome analysis were both normal. 232 
 233 
12 
 
 Family 5, heterozygous c.38G>A (p.Ser13Asn) mutation: A family from France (Figure 234 
1E) with Peters anomaly was ascertained. The index case (III:1) presented bilateral Peters 235 
anomaly while his mother presented unilateral Peters anomaly. Neurological development of the 236 
index case (III:1) was within normal ranges. There was no facial dysmorphism presented by the 237 
index case as by the affected mother (II:2) apart from one palatal tooth for the index case. The 238 
length, weight and OFC of the index case were at +1 SD at age 10 years. 239 
The grandmother (I:2), who carried the c.38G>A variant heterozygously, displayed bilateral 240 
nuclear and cortical cataract without any anterior segment anomaly. Because she only developed 241 
cataract at 70 years of age, we classified her as not affected (Figure 1E). We confirmed the 242 
mutation in the grandmother (I:2) on a new blood sample as well as on a saliva sample in which 243 
no mosaicism was further ascertained by ddPCR quantification (estimated fractional abundance 244 
of 50% for the mutated allele, Figure S1) in the analyzed tissues. By history, no other members 245 
from the mother’s side had any ocular or extra-ocular features. 246 
 247 
DISCUSSION 248 
 249 
The aim of this study was to identify mutations in PITX3 in patients with congenital cataracts 250 
accompanied by anterior segment dysgenesis or microphthalmia. We were able to identify four 251 
different mutations, including two novel ones, in five families (12 affected cases). 252 
Except for the p.Ser13Asn, all mutations described by us and others introduce a frameshift 253 
[10,15,17-20]. The phenotypic variability associated to these mutations was large even within 254 
members of the same family. Most of them were dominantly inherited and associated to cataract 255 
accompanied by additional eye disorders ranging from embryotoxon to microphthalmia. In 256 
contrast, Aldahmesh et al. described the only PITX3 mutation associated with autosomal 257 
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recessive inheritance to date [15]. The index case with a homozygous c.640_656del 258 
(p.(Ala214Argfs*42)) presented sclereocornea and microphthalmia and he was born from a 259 
healthy first cousin mating, both of whom were heterozygous for the PITX3 mutation [15]. 260 
Homozygously mutated patients were identified in two other families (Bidinost et al. and this 261 
report) but these mutations lead to ocular disorders even in heterozygous carriers [17]. Thus, in 262 
the latter families, the homozygous patients have a double-dose of a dominant mutation, while in 263 
the one presented by Aldahmesh et al., the mutation seemed to be truly recessive. Independently 264 
of the mode of inheritance, homozygous mutated patients seem to have a more severe phenotype 265 
than heterozygous ones. Indeed, all have severe ocular phenotypes as sclerocornea associated 266 
with microphthalmia (3/4) or severe ASMD (1/4). In addition, two of them presented with 267 
developmental delay. Here, we also presented two patients with heterozygous PITX3 mutations 268 
with developmental delay (Family 3, patient III:2) or autism (Family 4, patient II:1). The 269 
neurological involvement might be associated to the PITX3 mutation, however, we could not rule 270 
out a different cause as one patient presented with additional features (short stature, facial 271 
features and finger abnormalities) that were not previously associated with PITX3 mutations, and 272 
the other carrying a de novo PITX3 mutation had a familial history of autistic features. 273 
There is also a wide variability regarding the ocular involvement among heterozygous patients 274 
ranging from unilateral nasal posterior embryotoxon to congenital cataract and microphthalmia. 275 
This variability was evidenced even within patients from the same family, but also within the 276 
same individual as patient II:2 from family 5 presented with unilateral Peters anomaly with 277 
contralateral normal eye. This suggests that penetrance of PITX3 mutations may be incomplete. 278 
This was already demonstrated in the large family described by Aldahmesh et al. in which 1/31 279 
heterozygous patients was unaffected [15]. In Family 5, the penetrance of the p.Ser13Asn 280 
mutation was supposed to be incomplete as the asymptomatic grandmother, who presented with 281 
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late onset cataract, also carried the mutation. Besides, the hypothesis of mosaicism could not be 282 
demonstrated in the analyzed tissues (blood and saliva) as the fractional abundance of the 283 
mutated allele was similar to the expected for a fully heterozygous carrier in two different tissues 284 
(blood and saliva). In addition, the p.Ser13Asn mutation cosegregated with Peters anomaly in this 285 
family, a new phenotypic manifestation associated with this mutation as, to date, it has only been 286 
identified in a family with isolated congenital cataract [10]. One plausible explanation of 287 
phenotypic variability and incomplete penetrance is that stochastic effects, genetic background, 288 
and environmental factors during development might result in variable active protein available at 289 
different time points that can be crucial or detrimental during development [23-26].  290 
As previously mentioned, except for the (p.Ser13Asn), all PITX3 mutations known to date lead to 291 
a frameshift. The p.Ser13Asn variant is very rare in the general population (1/225438 alleles in 292 
the gnomeAD database), and it was previously identified de novo in a patient with congenital 293 
cataract [10]. This variant affects a conserved amino acid and was predicted to be deleterious by 294 
different prediction softwares (Polyphen-2 and Mutation Taster), but tolerated by SIFT software. 295 
Functional analyses that studied the consequences of this mutation on PITX3 function have 296 
demonstrated only minor functional effects in comparison to the p.Gly220Profs*95 mutant which 297 
showed a partial loss of function of the protein activity [27]. These functional studies identified a 298 
slightly decrease in the DNA binding ability of the p.Ser13Asn mutant, however a 23% decrease 299 
in its ability to increase reporter activity was found which may support our premise that this 300 
variant is disease-causing [27]. Of note, no other deleterious variants were identified among the 301 
187 genes screened in the index case carrying this mutation (case III:1, family 5). 302 
The genetic pathway in which PITX3 is involved is not elucidated yet. Knockdown of foxe3 and 303 
pitx3 in zebrafish by using morpholinos demonstrated that pitx3 is genetically upstream of foxe3 304 
since in pitx3 morphants the expression of foxe3 was abolished, while in foxe3 morphants, pitx3 305 
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expression was detected [28]. Also, Pitx3 is downregulated in lenses of heterozygous Pax6 306 
mutant mice, implying that Pax6 is genetically upstream of Pitx3 [29]. Mutations in PAX6 are 307 
associated with aniridia, congenital cataract, Peters anomaly and microphthalmia, amongst other 308 
ocular disorders; while mutations in FOXE3 are also associated with Peters anomaly, cataract, 309 
congenital aphakia, sclerocornea and microphthalmia. This phenotypic overlap between 310 
mutations in PAX6, PITX3 and FOXE3 suggests that the three genes could be involved in the 311 
same genetic pathway in humans as well as in mice and zebrafish. 312 
In conclusion, we have presented known and novel mutations in PITX3 that are causative of 313 
congenital cataract, ASMD (including Peters anomaly) and microphthalmia in families that show 314 
large phenotypic variability. Further investigations are needed to elucidate the cause of this 315 
clinical variability as well as the molecular pathways that involve PITX3 during ocular 316 
development. 317 
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TITLES AND LEGENDS TO FIGURES  436 
Figure 1: Families affected by PITX3 mutations. “M” indicates the corresponding mutation and 437 
“+” the wild-type allele. The arrows indicate the index case. Dark-filled symbols indicate the 438 
individual was affected with an ocular developmental disorder, more details are shown in Table 439 
1. Grey filled symbols in Family 2 show an unclear affection status (these patients presented only 440 
embryotoxon, a common clinical manifestation).  441 
Figure 2: Electropherograms showing the genetic defects in PITX3 in the different families.  442 
Figure 3: Schematic representation of PITX3 protein domains with the mutations associated with 443 
congenital cataract. In dark gray, the homeodomain, and in light grey, the OAR domains are 444 
indicated [27]. The mutations reported in this study are underlined [10,15-18]. Novel mutations 445 
are indicated with the superscript ‘N’.   446 
Table 1: Genotype and detailed phenotypic description of the affected individuals described here.  447 
 448 
 449 
 450 
 451 
 452 
 453 
 454 
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Table 1: Genotype and detailed phenotypic description of the affected individuals described here.  
Family Individual Mutation Ocular phenotype 
Extraocular 
phenotype 
1 
II.5 (index) p.[Gly220Profs*95];[=] 
Peters anomaly in one 
eye and cataract in the 
other eye 
None 
I.4 Not tested 
Posterior embryotoxon 
and congenial cataract 
None 
II.4 p.[Gly220Profs*95];[=] 
Congenital bilateral 
cataract 
None 
III.3 Not tested 
Peters anomaly and 
posterior embryotoxon 
None 
II.7 p.[Gly220Profs*95];[=] Congenital cataract. None 
2 
II.1 (index) p.[(Leu225Trpfs*84)];[(Leu225Trpfs*84)] 
Bilateral congenital 
sclereocornea and ASMD 
Facial features 
Broad thumbs 
II.2 p.[(Leu225Trpfs*84)];[=] 
Nasal posterior 
embryotoxon in the left 
eye 
None 
3 
II.2 (index) Not tested 
Bilateral Peters anomaly 
 
Short stature 
Facial features 
Short hands with 
tapering fingers 
Psychomotor 
delay 
I.2 Not tested Juvenile bilateral cataract None 
4 II:1 (index) p.[Gly220Profs*95];[=] 
Bilateral congenital 
cataract and 
microphthalmia 
Autism 
Double row of 
teeth 
5 
III:1(index) p.[Gly220Profs*95];[=] Bilateral Peters anomaly None 
II:2 p.[(Ile194Metfs*115)];[=] Unilateral Peters anomaly None 
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SUPPLEMENTARY DATA 
Table S1: List of the 186 known and candidate genes involved in ocular development that were 
part of the targeted sequencing panel.  
ABCG5  CRABP2 GAS1 NAT1 SFRP2 FOXH1 
ADAM17 RBP1 GBX2 NEUROD4 SHH  SCLT1 
ADCY7 CREG1  GDF2 NOTCH1 SIX3 TBC1D32 
AHR CRYAA GDF6 NOTCH4 SIX6 GJA8 
AK9 CRYBA1 GJA1 TENM3 SLC4A7  CRYGC 
ALDH1A1 CRYGA GLI1 OLFM2 SMO TBC1D20 
ALDH1A2 CRYGD GLI2 OTX2 SMOC1 RAB18 
ALDH1A3 VCAN GLI3 PAX2 SNX3 NAA10 
ALDH1L1 CYP26A1 GLIS3 PAX3 SOX1 PRSS3 
ALG2 CYP26B1 GPRC5C PAX6 SOX10 CTBP2 
ALKBH1 CYP26C1 GRIP1 PBX1 SOX14 MTCH2 
ASXL1 DHH HCCS PDS5A SOX2 
 ATOH7 DHRS3 HHAT PITX2 SOX21 
 B3GALTL DISP1 HHIP PITX3 STRA6 
 BCMO1 DKK1 HMGB3 PLCG1  SUFU 
 BCOR DMBX1 HMX1 POMT2 SV2C 
 BEST1 DOCK2    HPGD PRSS56 SYNE1  
 BFSP1 EFHD1 IFT172 PTCH1 TADA3 
 BFSP2 EN1 IGBP1 PTCH2 IL10 
 BMP4 ENTPD2 IHH RAB23 TMEM150A  
 BMP7 EPSTI1  IKBKG RAB3IL1  TMEM170A 
 ZCCHC24 EYA1 IL1R1   RAB3GAP1 TMEM175 
 GRCC10  EYA2 KIF3A RAB3GAP2 TMEM67 
 C1orf101  EYA3 KRT27  RARA TRPV4  
 C3orf52    FAT1 LGR4 RARB TSHZ2 
 CDH20 FAT4 LIM2 RARG TUBGCP6   
 CASC3 FBXW11  LRAT RAX VAX1 
 CASP3 FGF19 MACF1  RBP4 VAX2 
 CDON FLNA MAF RDH10 VSX2 
 CES5A  FNBP4 MAFB CLVS1 ZIC2 
 CHD7 FOXE3 MDH1B   RPP40   ZNF335 
 CHRD FOXN4 MEIS1 RXRA NKX2.1 
 CLDN19 FRAS1 MFRP RXRB NKX2.2 
 COX7B FREM2 MIR204 RXRG IRX1 
 CRABP1 FRS2 MITF SCARB1 IRX2 
  
2 
 
Figure S2. Absolute quantification of the allele abundance for the mutation c.38G>A, 
p.Ser13Asn in Family 5. Digital Droplet PCR (ddPCR) assays were performed using Taqman 
Genotyping assays. Fractional abundance of mutated allele, represented in percentage, was 
calculated for the FAM-positive droplets vs VIC- (wild type allele) positive droplets 
(FAM/FAM+VIC). Experiments were performed in quadruplicated. Blood and saliva samples 
were tested in the asymptomatic grandmother (I:2) and compared with the index case (III:1) as 
heterozygous symptomatic carrier and the unaffected grandfather (I:1) as wild-type individual.  
Table S1: Primers sequences for the amplification and sequencing of PITX3 exonic and splice 
site regions by Sanger sequencing are indicated. 
 
 
PRIMERS 
 
EXON 
 
PRIMER SEQUENCES 
SEQUENCED 
REGIONS 
(ENST00000370002) 
SIZE 
(bp) 
SEQ-PITX3-
EXON2-F 
2 
GAAAGGCGCCAGGGAATTTA 
c.-91_118+118 366 
SEQ-PITX3-
EXON2-R 
CAAGCCAGCGCATATTCTC 
SEQ-PITX3-
EXON3-F 
3 
CGGTGGGAGCCAGCGAGTG 
c.119-74_c.321+46 362 
SEQ-PITX3-
EXON3-R 
CTCCGGGTCGCAGGCTGAG 
SEQ-PITX3-
EXON4.1-F 
4 
CCGCCCTTCAGCCGCTGGGA 
c.322-41_c.704 467 
SEQ-PITX3-
EXON4.1-R 
CGGCCGAGGCATAAGGGCAG
GA 
SEQ-PITX3-
EXON4.2-F 
CCATCGCCGCCTCCATGGT 
c.597_c.*70 423 
SEQ-PITX3-
EXON4.2-R 
GGGCGGGAGCAAGCCAGTCA
A 
